[(7-Carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-9-yl)methyl]hydrogenfumarat

489-50-9

CAS-Nr.: 489-50-9

Bezeichnung:: [(7-Carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-9-yl)methyl]hydrogenfumarat

Englisch Name:: FUMARPROTOCETRARIC ACID

Synonyma:: FUMARPROTOCETRARIC ACID;Fumarylprotocetraric acid;FUMARPROTOCETRARIC ACID(RG);[(7-carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-9-yl)methyl] hydrogen fumarate;9-(3-Carboxy-acryloyloximethyl)-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[B,E][1,4]dioxepin-7-carboxylic acid;But-2-enedioic acid mono-(7-carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[B,E][1,4]dioxepin-9-ylmethyl) ester;2-Butenedioic acid (2E)-, 1-[(7-carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-9-yl)methyl] ester;2-Butenedioic acid, mono[(7-carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[B,E][1,4]dioxepin-9-yl)methyl] ester, (2E)-;9-({[(2E)-3-Carboxyprop-2-enoyl]oxy}methyl)-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[B,E][1,4]dioxepine-7-carboxylic acid;(E)-2-Butenedioic acid hydrogen 1-[(7-carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-9-yl)methyl] ester

CBNumber:: CB5202441

Summenformel:: C22H16O12

Molgewicht:: 472.36

MOL-Datei:: 489-50-9.mol

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 15

[(7-Carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-9-yl)methyl]hydrogenfumarat Eigenschaften

Schmelzpunkt:: 250～260℃

Siedepunkt:: 805.7±65.0 °C(Predicted)

Dichte: 1.628±0.06 g/cm3(Predicted)

pka: 2.12±0.20(Predicted)

LogP: 4.693 (est)

Sicherheit

Risiko- und Sicherheitserklärung
Gefahreninformationscode (GHS)

Bildanzeige (GHS)

Alarmwort

Warnung

Gefahrenhinweise

Code	Gefahrenhinweise	Gefahrenklasse	Abteilung	Alarmwort	Symbol	P-Code
H317	Kann allergische Hautreaktionen verursachen.	Sensibilisierung der Haut	Kategorie 1A	Warnung	src="/GHS07.jpg" width="20" height="20" />	P261, P272, P280, P302+P352,P333+P313, P321, P363, P501

Sicherheit

P280	Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P302+P352	BEI BERÜHRUNG MIT DER HAUT: Mit viel Wasser/... (Hersteller kann, falls zweckmäßig, ein Reinigungsmittel angeben oder, wenn Wasser eindeutig ungeeignet ist, ein alternatives Mittel empfehlen) waschen.

[(7-Carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-9-yl)methyl]hydrogenfumarat Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

antibacterial

[(7-Carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-9-yl)methyl]hydrogenfumarat Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

[(7-Carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-9-yl)methyl]hydrogenfumarat Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 15)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
BOC Sciences	1-631-485-4226; 16314854226	info@bocsci.com	United States	14059	65
Shanghai Tauto Biotech Co., Ltd.	021-51320588	tauto@tautobiotech.com	China	3989	66
Shanghai TaoSu Biochemical Technology Co., Ltd.	021-33632979	info@tsbiochem.com	China	8073	58
Chengdu Peter-like Biotechnology Co., Ltd.	028-81700200 18108052721	2850505130@qq.com	China	5182	58
Meng Cheng Technology (Shanghai) Co., LTD	400-820-6829	sales@mitachieve.com	China	8864	58
Zhejiang Huida Biotech Co., LTD	0571-89903882 13626641628	jiangnan@huidabiotech.com	China	3661	58
Zhejiang Huida Biotech Co., LTD	0571-0571-89903882 15990081639	sunshixuan@huidabiotech.com	China	3705	58
Shaanxi DIDU pharmaceutical and Chemical Co., Ltd	17691182729 18161915376	1046@dideu.com	China	10008	58
Carbosynth	--	sales@carbosynth.com	United Kingdom	6018	58

489-50-9([(7-Carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-9-yl)methyl]hydrogenfumarat)Verwandte Suche:

Benzylacrylat 3,4-Dimethylbenzylalkohol [(7-Carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-9-yl)methyl]hydrogenfumarat Methyl-2,4-dihydroxy-m-toluat 5-Methoxysalicylaldehyd Alkohol 3-phenoxybenzyl 2-Hydroxy-3-methylbenzoesäure 2-Phenoxybenzoesure 2,4-Dimethylresorcin 4-Hydroxy-o-toluylsure m-Methylbenzylacetat 3-Methoxysalicylalkohol 3,5-Dimethylanisol 2,6-Dimethylhydrochinon 2,5-Dihydroxybenzaldehyd Methyl-3-methylsalicylat 3,5-Xylenol

[(7-carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-9-yl)methyl] hydrogen fumarate
FUMARPROTOCETRARIC ACID
(E)-2-Butenedioic acid hydrogen 1-[(7-carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-9-yl)methyl] ester
4-Formyl-3,8-dihydroxy-9-[[[(E)-4-hydroxy-1,4-dioxo-2-butenyl]oxy]methyl]-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-7-carboxylic acid
Fumarylprotocetraric acid
2-Butenedioic acid, mono[(7-carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[B,E][1,4]dioxepin-9-yl)methyl] ester, (2E)-
9-({[(2E)-3-Carboxyprop-2-enoyl]oxy}methyl)-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[B,E][1,4]dioxepine-7-carboxylic acid
9-(3-Carboxy-acryloyloximethyl)-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[B,E][1,4]dioxepin-7-carboxylic acid
But-2-enedioic acid mono-(7-carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[B,E][1,4]dioxepin-9-ylmethyl) ester
Inchi=1/C22H16o12/C1-8-5-12(24)10(6-23)19-15(8)22(31)34-20-11(7-32-14(27)4-3-13(25)26)17(28)16(21(29)30)9(2)18(20)33-19/H3-6,24,28H,7H2,1-2H3,(H,25,26)(H,29,30)/B4-3
FUMARPROTOCETRARIC ACID(RG)
2-Butenedioic acid (2E)-, 1-[(7-carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-9-yl)methyl] ester
489-50-9
C22H16O12